NCT03608007 2020-01-09X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene RearrangementBetta Pharmaceuticals Co., Ltd.Phase 2 Unknown69 enrolled
NCT03536481 2019-07-24Bioequivalency Study of Ensartinib Capsules in Healthy VolunteersBetta Pharmaceuticals Co., Ltd.Phase 1 Completed74 enrolled